|
Novel Approaches to Radiation Therapy and Integration of Targeted Therapy with Radiation Treatment in Solid Tumors
Location: Ho Chi Ming City or Hue or Hanoi, Vietnam
Dates: 3/6/2009 to 3/7/2009
Conference duration: 2 days
Objectives
- To discuss the latest technical advances in radiation therapy
including intensity modulated radiation therapy (IMRT) and image guided
radiation therapy (IGRT)
- To provide guidance of how best to implement these technologies in the clinics in Vietnam
- To discuss the utility of different targeted therapies in solid
tumor and how to integrate them with radiation therapy in the
management of solid tumors.
|
| Intensity modulated radiation therapy (IMRT) and image guided
radiation therapy (IGRT) represent the latest technical advances in
radiation therapy within the last 5 years. They represent new paradigms
that require knowledge of multi-modality imaging, setup uncertainties,
internal organ motion, tumor control probabilities, normal tissue
complication probabilities, three-dimensional dose calculation and
optimization of radiation delivery. Although these new processes of
treatment planning and delivery have potential for improving the
therapeutic ratio and reducing toxicity, they do not come without a
price and a risk. These techniques require expensive hardware, complex
multi-modality imaging and significant personnel resources. They can
also be easily misunderstood and misapplied, resulting in excess
complications that will negate their potential benefits. A major
objective of this meeting is to educate the Vietnamese radiation
oncologist, physicists and their supporting staff on the safe
implementation of IMRT and IGRT in the clinics.
Parallel to the technological advances in radiation oncology is the
explosion of novel targeted therapies, focusing on blocking different
signaling pathways that promote tumor progression. Several targeted
therapies, while by themselves have minimal activities, have been shown
to be synergistic with radiation and chemotherapy and improve survivals
in patients with different solid tumors. The integration of these
targeted drugs to conventional therapy represent a new paradigm in the
management of solid tumors. The second major goal of this course is to
educate Vietnamese oncologist on these novel targeted therapy and how
best to combine them with conventional treatment.
Audience: Practicing radiation oncologists, medical oncologist physicists, and supporting staff members in Vietnam
Program Speaker List
Dr. Quynh-Thu Le, M.D.
Radiation Oncology, Head and Neck
Stanford Cancer Center
Stanford CA |
Dr. Albert Koong, M.D Ph.D.
Radiation Oncology, Gastrointestinal
Stanford Cancer Center
Stanford CA |
Dr. Anh Thinh
Radiation Oncology
Saigon Cancer Center
Ho Chi Min City, Vietnam |
Andy Quon
Radiology, Nuclear Medicine
Stanford Cancer Center
Stanford CA |
Dr. Amato Giaccia
Radiation Oncology
Stanford Cancer Center
Stanford CA |
Tom Bucholtz
Radiation Oncology
M.D. Anderson Cancer Center
Houston TX |
Dr. James Balter, Ph.D.
Radiation Oncology
University of Michigan
An Arbor MI |
Kenneth Hu
Radiation Oncology,
Beth Israel Hospital
New York NY |
Dr. Ping Xia, Ph.D.
Radiation Oncology
University of California San Francisco
San Francisco CA |
June Corry
Radiation Oncology
Peter MacCallum Cancer center
Melbourne, Australia |
Dr. Iris Gibbs, M.D.
Radiation Oncology, Brain and Central Nervous System
Stanford Cancer Center
Stanford CA |
|
|
Schedule
| March 6th 2009 |
| 08:00-08:15 |
Introduction (Quynh Le, Stanford University) |
| 08:15-09:05 |
The Status of Radiation Therapy in Vietnam (Dr. Thinh, Saigon
Cancer Center) |
| 09:05-09:15 |
Q&A |
| 09:15-10:05 |
The Effect of Radiation Fractionation and Volume on Normal Tissue
Toxicity (Dr. Amato Giaccia, Stanford University) |
| 10:05-10:15 |
Q&A |
| 10:15-10:30 |
Coffee Break (15 min) |
| 10:30-11:20 |
Transition from 2D to 3D to IMRT to IGRT (Dr. Quynh Le, Stanford) |
| 11:20-11:30 |
Q&A |
| 11:30-12:20 |
Effect of Patient and Tumor Immobilization on Radiation Targeting
(Dr. Jim Balter, University of Michigan) |
| 12:20-12:30 |
Q&A |
| 12:30-14:00 |
Lunch Break |
| 14:00-14:50 |
Practical Aspects in Implementing 3DCRT/ IMRT (Dr. Jim Balter, University of Michigan) |
| 14:50-15:00 |
Q&A |
| 15:00-15:50 |
How to simplify IMRT planning and delivery (Dr. Ping Xia, UCSF) |
| 15:50-16:00 |
Q&A |
| 18:00-19:00 |
Dinner |
| March 7th 2009 |
| 08:00-08:50 |
Stereotactic Radiation Therapy for Intracranial Tumors (Dr. Iris
Gibbs, Stanford University) |
| 08:50-09:00 |
Q&A |
| 09:00-09:50 |
Stereotactic Radiation Therapy for Extracranial (Dr. Albert Koong,
Stanford University) |
| 09:50-10:00 |
Q&A |
| 10:00-10:15 |
Coffee Break (15 min) |
| 10:15-11:05 |
How to Distinguish Treatment-related Toxicity Versus Recurrent
Cancers (Andy Quon, Stanford Radiology) |
| 11:05-11:15 |
Q&A |
| 11:15-12:05 |
The Role of Radiation Therapy in Breast Cancers with a Focus on
Breast Conservation Strategies (Tom Bucholtz, MDACC) |
| 12:05-12:15 |
Q&A |
| 12:15-13:30 |
Lunch Break |
| 13:30-14:20 |
Brachytherapy for Head and Neck and Cervical Cancers (Dr. Kenneth Hu, Beth Isreal Hospital) |
| 14:20-14:30 |
Q&A |
| 14:30-15:20 |
How to Manage Recurrent Nasopharyngeal Carcinoma (Dr. June Corry, Peter MacCallum Cancer Centre, Melbourne, Australia) |
| 15:20-16:30 |
Q&A |
| 16:30-17:30 |
A Tour of the Ho Chi Minh City Oncology Hospital |
|
|